nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.209	0.294	CbGbCtD
Prochlorperazine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0854	0.12	CbGbCtD
Prochlorperazine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0854	0.12	CbGbCtD
Prochlorperazine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0761	0.107	CbGbCtD
Prochlorperazine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0717	0.101	CbGbCtD
Prochlorperazine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0484	0.0682	CbGbCtD
Prochlorperazine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0462	0.065	CbGbCtD
Prochlorperazine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0412	0.058	CbGbCtD
Prochlorperazine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0242	0.034	CbGbCtD
Prochlorperazine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0228	0.0321	CbGbCtD
Prochlorperazine—Brain injury—Aminophylline—chronic obstructive pulmonary disease	0.0155	0.0731	CcSEcCtD
Prochlorperazine—Ileus paralytic—Tiotropium—chronic obstructive pulmonary disease	0.0049	0.0231	CcSEcCtD
Prochlorperazine—Pigmentation skin—Prednisone—chronic obstructive pulmonary disease	0.00369	0.0174	CcSEcCtD
Prochlorperazine—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00302	0.0142	CcSEcCtD
Prochlorperazine—Pulmonary function test decreased—Aminophylline—chronic obstructive pulmonary disease	0.00299	0.0141	CcSEcCtD
Prochlorperazine—Respiratory depression—Aminophylline—chronic obstructive pulmonary disease	0.00299	0.0141	CcSEcCtD
Prochlorperazine—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.00222	0.0105	CcSEcCtD
Prochlorperazine—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00212	0.00998	CcSEcCtD
Prochlorperazine—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00997	CcSEcCtD
Prochlorperazine—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00997	CcSEcCtD
Prochlorperazine—Coma—Aminophylline—chronic obstructive pulmonary disease	0.00205	0.0097	CcSEcCtD
Prochlorperazine—Mydriasis—Salbutamol—chronic obstructive pulmonary disease	0.00203	0.00956	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Prednisone—chronic obstructive pulmonary disease	0.00202	0.00952	CcSEcCtD
Prochlorperazine—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00941	CcSEcCtD
Prochlorperazine—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00199	0.0094	CcSEcCtD
Prochlorperazine—Embolism venous—Prednisolone—chronic obstructive pulmonary disease	0.00184	0.00867	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.00816	CcSEcCtD
Prochlorperazine—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00798	CcSEcCtD
Prochlorperazine—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00798	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00169	0.00796	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00791	CcSEcCtD
Prochlorperazine—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.00167	0.0079	CcSEcCtD
Prochlorperazine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.00155	0.00733	CcSEcCtD
Prochlorperazine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00146	0.00691	CcSEcCtD
Prochlorperazine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.00676	CcSEcCtD
Prochlorperazine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.00669	CcSEcCtD
Prochlorperazine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00652	CcSEcCtD
Prochlorperazine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00644	CcSEcCtD
Prochlorperazine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00644	CcSEcCtD
Prochlorperazine—Eczema—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00639	CcSEcCtD
Prochlorperazine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00636	CcSEcCtD
Prochlorperazine—Embolism venous—Prednisone—chronic obstructive pulmonary disease	0.00133	0.0063	CcSEcCtD
Prochlorperazine—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00628	CcSEcCtD
Prochlorperazine—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00616	CcSEcCtD
Prochlorperazine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00608	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00601	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00601	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00601	CcSEcCtD
Prochlorperazine—Increased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00589	CcSEcCtD
Prochlorperazine—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00574	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00567	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.0012	0.00566	CcSEcCtD
Prochlorperazine—Infection—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00564	CcSEcCtD
Prochlorperazine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00551	CcSEcCtD
Prochlorperazine—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00548	CcSEcCtD
Prochlorperazine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00514	CcSEcCtD
Prochlorperazine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00507	CcSEcCtD
Prochlorperazine—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00507	CcSEcCtD
Prochlorperazine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00507	CcSEcCtD
Prochlorperazine—Influenza—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00507	CcSEcCtD
Prochlorperazine—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00496	CcSEcCtD
Prochlorperazine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00496	CcSEcCtD
Prochlorperazine—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00495	CcSEcCtD
Prochlorperazine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00491	CcSEcCtD
Prochlorperazine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00486	CcSEcCtD
Prochlorperazine—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00478	CcSEcCtD
Prochlorperazine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00478	CcSEcCtD
Prochlorperazine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00476	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000969	0.00457	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000969	0.00457	CcSEcCtD
Prochlorperazine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000956	0.00451	CcSEcCtD
Prochlorperazine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000955	0.00451	CcSEcCtD
Prochlorperazine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000951	0.00449	CcSEcCtD
Prochlorperazine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000938	0.00443	CcSEcCtD
Prochlorperazine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000921	0.00435	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000915	0.00432	CcSEcCtD
Prochlorperazine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000914	0.00431	CcSEcCtD
Prochlorperazine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000904	0.00427	CcSEcCtD
Prochlorperazine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000903	0.00426	CcSEcCtD
Prochlorperazine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000886	0.00418	CcSEcCtD
Prochlorperazine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000881	0.00416	CcSEcCtD
Prochlorperazine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000874	0.00412	CcSEcCtD
Prochlorperazine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000852	0.00402	CcSEcCtD
Prochlorperazine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000847	0.004	CcSEcCtD
Prochlorperazine—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000847	0.004	CcSEcCtD
Prochlorperazine—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000847	0.004	CcSEcCtD
Prochlorperazine—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.000831	0.00392	CcSEcCtD
Prochlorperazine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000809	0.00382	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000802	0.00379	CcSEcCtD
Prochlorperazine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000797	0.00376	CcSEcCtD
Prochlorperazine—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000796	0.00376	CcSEcCtD
Prochlorperazine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000796	0.00375	CcSEcCtD
Prochlorperazine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000772	0.00364	CcSEcCtD
Prochlorperazine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000768	0.00362	CcSEcCtD
Prochlorperazine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000768	0.00362	CcSEcCtD
Prochlorperazine—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000767	0.00362	CcSEcCtD
Prochlorperazine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000759	0.00358	CcSEcCtD
Prochlorperazine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000758	0.00358	CcSEcCtD
Prochlorperazine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000757	0.00357	CcSEcCtD
Prochlorperazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000754	0.00356	CcSEcCtD
Prochlorperazine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000752	0.00355	CcSEcCtD
Prochlorperazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00075	0.00354	CcSEcCtD
Prochlorperazine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000735	0.00347	CcSEcCtD
Prochlorperazine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000727	0.00343	CcSEcCtD
Prochlorperazine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000727	0.00343	CcSEcCtD
Prochlorperazine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000726	0.00342	CcSEcCtD
Prochlorperazine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.00342	CcSEcCtD
Prochlorperazine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000719	0.00339	CcSEcCtD
Prochlorperazine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000719	0.00339	CcSEcCtD
Prochlorperazine—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000716	0.00338	CcSEcCtD
Prochlorperazine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000705	0.00333	CcSEcCtD
Prochlorperazine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000701	0.00331	CcSEcCtD
Prochlorperazine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000701	0.00331	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000695	0.00328	CcSEcCtD
Prochlorperazine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000688	0.00324	CcSEcCtD
Prochlorperazine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000688	0.00324	CcSEcCtD
Prochlorperazine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000687	0.00324	CcSEcCtD
Prochlorperazine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.00324	CcSEcCtD
Prochlorperazine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000684	0.00323	CcSEcCtD
Prochlorperazine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000684	0.00323	CcSEcCtD
Prochlorperazine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000684	0.00323	CcSEcCtD
Prochlorperazine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000679	0.00321	CcSEcCtD
Prochlorperazine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000673	0.00318	CcSEcCtD
Prochlorperazine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00067	0.00316	CcSEcCtD
Prochlorperazine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000662	0.00312	CcSEcCtD
Prochlorperazine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000653	0.00308	CcSEcCtD
Prochlorperazine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000653	0.00308	CcSEcCtD
Prochlorperazine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000649	0.00306	CcSEcCtD
Prochlorperazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000647	0.00305	CcSEcCtD
Prochlorperazine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.00305	CcSEcCtD
Prochlorperazine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00064	0.00302	CcSEcCtD
Prochlorperazine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00064	0.00302	CcSEcCtD
Prochlorperazine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000637	0.00301	CcSEcCtD
Prochlorperazine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000635	0.003	CcSEcCtD
Prochlorperazine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000634	0.00299	CcSEcCtD
Prochlorperazine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000623	0.00294	CcSEcCtD
Prochlorperazine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000623	0.00294	CcSEcCtD
Prochlorperazine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00291	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000611	0.00288	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000611	0.00288	CcSEcCtD
Prochlorperazine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000611	0.00288	CcSEcCtD
Prochlorperazine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000611	0.00288	CcSEcCtD
Prochlorperazine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000607	0.00286	CcSEcCtD
Prochlorperazine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000607	0.00286	CcSEcCtD
Prochlorperazine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000601	0.00284	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000598	0.00282	CcSEcCtD
Prochlorperazine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000598	0.00282	CcSEcCtD
Prochlorperazine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000594	0.0028	CcSEcCtD
Prochlorperazine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000593	0.0028	CcSEcCtD
Prochlorperazine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000593	0.0028	CcSEcCtD
Prochlorperazine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000591	0.00279	CcSEcCtD
Prochlorperazine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000588	0.00278	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000586	0.00276	CcSEcCtD
Prochlorperazine—Meclizine—CYP1A2—chronic obstructive pulmonary disease	0.000581	0.0497	CrCbGaD
Prochlorperazine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000581	0.00274	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00272	CcSEcCtD
Prochlorperazine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00272	CcSEcCtD
Prochlorperazine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.0027	CcSEcCtD
Prochlorperazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000571	0.00269	CcSEcCtD
Prochlorperazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000571	0.00269	CcSEcCtD
Prochlorperazine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000568	0.00268	CcSEcCtD
Prochlorperazine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00056	0.00264	CcSEcCtD
Prochlorperazine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000557	0.00263	CcSEcCtD
Prochlorperazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000552	0.00261	CcSEcCtD
Prochlorperazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000552	0.00261	CcSEcCtD
Prochlorperazine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000544	0.00257	CcSEcCtD
Prochlorperazine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.00257	CcSEcCtD
Prochlorperazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000543	0.00256	CcSEcCtD
Prochlorperazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000543	0.00256	CcSEcCtD
Prochlorperazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000541	0.00255	CcSEcCtD
Prochlorperazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.00254	CcSEcCtD
Prochlorperazine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.00253	CcSEcCtD
Prochlorperazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000532	0.00251	CcSEcCtD
Prochlorperazine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000531	0.0025	CcSEcCtD
Prochlorperazine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000529	0.0025	CcSEcCtD
Prochlorperazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00246	CcSEcCtD
Prochlorperazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00246	CcSEcCtD
Prochlorperazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.00246	CcSEcCtD
Prochlorperazine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00052	0.00246	CcSEcCtD
Prochlorperazine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00243	CcSEcCtD
Prochlorperazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00242	CcSEcCtD
Prochlorperazine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000506	0.00239	CcSEcCtD
Prochlorperazine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000505	0.00239	CcSEcCtD
Prochlorperazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00237	CcSEcCtD
Prochlorperazine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0005	0.00236	CcSEcCtD
Prochlorperazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00233	CcSEcCtD
Prochlorperazine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000485	0.00229	CcSEcCtD
Prochlorperazine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.00229	CcSEcCtD
Prochlorperazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000483	0.00228	CcSEcCtD
Prochlorperazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000483	0.00228	CcSEcCtD
Prochlorperazine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.00225	CcSEcCtD
Prochlorperazine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.00225	CcSEcCtD
Prochlorperazine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00224	CcSEcCtD
Prochlorperazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000474	0.00224	CcSEcCtD
Prochlorperazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000473	0.00223	CcSEcCtD
Prochlorperazine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00219	CcSEcCtD
Prochlorperazine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00216	CcSEcCtD
Prochlorperazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.00215	CcSEcCtD
Prochlorperazine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00045	0.00212	CcSEcCtD
Prochlorperazine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.00212	CcSEcCtD
Prochlorperazine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000441	0.00208	CcSEcCtD
Prochlorperazine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00204	CcSEcCtD
Prochlorperazine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00204	CcSEcCtD
Prochlorperazine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.002	CcSEcCtD
Prochlorperazine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000423	0.002	CcSEcCtD
Prochlorperazine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000416	0.00196	CcSEcCtD
Prochlorperazine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00193	CcSEcCtD
Prochlorperazine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000405	0.00191	CcSEcCtD
Prochlorperazine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00191	CcSEcCtD
Prochlorperazine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00191	CcSEcCtD
Prochlorperazine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.000403	0.0344	CrCbGaD
Prochlorperazine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00187	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000389	0.00184	CcSEcCtD
Prochlorperazine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00182	CcSEcCtD
Prochlorperazine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00182	CcSEcCtD
Prochlorperazine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00182	CcSEcCtD
Prochlorperazine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00182	CcSEcCtD
Prochlorperazine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00181	CcSEcCtD
Prochlorperazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00181	CcSEcCtD
Prochlorperazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00181	CcSEcCtD
Prochlorperazine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000382	0.0018	CcSEcCtD
Prochlorperazine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.0018	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000381	0.0018	CcSEcCtD
Prochlorperazine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00178	CcSEcCtD
Prochlorperazine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00178	CcSEcCtD
Prochlorperazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00177	CcSEcCtD
Prochlorperazine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00175	CcSEcCtD
Prochlorperazine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00172	CcSEcCtD
Prochlorperazine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00171	CcSEcCtD
Prochlorperazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.0017	CcSEcCtD
Prochlorperazine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.00166	CcSEcCtD
Prochlorperazine—Domperidone—CYP1A2—chronic obstructive pulmonary disease	0.000346	0.0295	CrCbGaD
Prochlorperazine—Cyamemazine—HTR2A—chronic obstructive pulmonary disease	0.00034	0.029	CrCbGaD
Prochlorperazine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.00156	CcSEcCtD
Prochlorperazine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.00156	CcSEcCtD
Prochlorperazine—Nefazodone—SLC6A4—chronic obstructive pulmonary disease	0.000315	0.0269	CrCbGaD
Prochlorperazine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00143	CcSEcCtD
Prochlorperazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.00141	CcSEcCtD
Prochlorperazine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00139	CcSEcCtD
Prochlorperazine—Aripiprazole—SLC6A4—chronic obstructive pulmonary disease	0.000293	0.025	CrCbGaD
Prochlorperazine—Trazodone—SLC6A4—chronic obstructive pulmonary disease	0.000292	0.0249	CrCbGaD
Prochlorperazine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000278	0.00131	CcSEcCtD
Prochlorperazine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00128	CcSEcCtD
Prochlorperazine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00127	CcSEcCtD
Prochlorperazine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00124	CcSEcCtD
Prochlorperazine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000255	0.0012	CcSEcCtD
Prochlorperazine—Thiothixene—CYP1A2—chronic obstructive pulmonary disease	0.000249	0.0213	CrCbGaD
Prochlorperazine—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.000249	0.0213	CrCbGaD
Prochlorperazine—Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.000244	0.0208	CrCbGaD
Prochlorperazine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.00115	CcSEcCtD
Prochlorperazine—Nefazodone—HTR2A—chronic obstructive pulmonary disease	0.000242	0.0207	CrCbGaD
Prochlorperazine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00113	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00113	CcSEcCtD
Prochlorperazine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00113	CcSEcCtD
Prochlorperazine—Mianserin—SLC6A4—chronic obstructive pulmonary disease	0.000236	0.0202	CrCbGaD
Prochlorperazine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000233	0.0011	CcSEcCtD
Prochlorperazine—Aripiprazole—HTR2A—chronic obstructive pulmonary disease	0.000225	0.0192	CrCbGaD
Prochlorperazine—Trazodone—HTR2A—chronic obstructive pulmonary disease	0.000224	0.0192	CrCbGaD
Prochlorperazine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00103	CcSEcCtD
Prochlorperazine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	0.000218	0.0187	CrCbGaD
Prochlorperazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00103	CcSEcCtD
Prochlorperazine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.000216	0.0185	CrCbGaD
Prochlorperazine—Mianserin—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.0184	CrCbGaD
Prochlorperazine—Fluphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.0184	CrCbGaD
Prochlorperazine—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.000214	0.0182	CrCbGaD
Prochlorperazine—Thiothixene—HTR2A—chronic obstructive pulmonary disease	0.00021	0.0179	CrCbGaD
Prochlorperazine—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.00021	0.0179	CrCbGaD
Prochlorperazine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000984	CcSEcCtD
Prochlorperazine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.000983	CcSEcCtD
Prochlorperazine—Mesoridazine—HTR2A—chronic obstructive pulmonary disease	0.000207	0.0177	CrCbGaD
Prochlorperazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000978	CcSEcCtD
Prochlorperazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00097	CcSEcCtD
Prochlorperazine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.0168	CrCbGaD
Prochlorperazine—Desipramine—ADRB2—chronic obstructive pulmonary disease	0.000191	0.0164	CrCbGaD
Prochlorperazine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000901	CcSEcCtD
Prochlorperazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000896	CcSEcCtD
Prochlorperazine—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000188	0.016	CrCbGaD
Prochlorperazine—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	0.000185	0.0158	CrCbGaD
Prochlorperazine—Fluphenazine—HTR2A—chronic obstructive pulmonary disease	0.000182	0.0155	CrCbGaD
Prochlorperazine—Mianserin—HTR2A—chronic obstructive pulmonary disease	0.000182	0.0155	CrCbGaD
Prochlorperazine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000836	CcSEcCtD
Prochlorperazine—Methotrimeprazine—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.0151	CrCbGaD
Prochlorperazine—Propiomazine—HTR2A—chronic obstructive pulmonary disease	0.000175	0.0149	CrCbGaD
Prochlorperazine—Desipramine—SLC6A4—chronic obstructive pulmonary disease	0.000174	0.0149	CrCbGaD
Prochlorperazine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	0.000172	0.0147	CrCbGaD
Prochlorperazine—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.0145	CrCbGaD
Prochlorperazine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000802	CcSEcCtD
Prochlorperazine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	0.000166	0.0142	CrCbGaD
Prochlorperazine—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	0.000165	0.0141	CrCbGaD
Prochlorperazine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00075	CcSEcCtD
Prochlorperazine—Desipramine—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.0135	CrCbGaD
Prochlorperazine—Thioridazine—HTR2A—chronic obstructive pulmonary disease	0.000156	0.0134	CrCbGaD
Prochlorperazine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.0131	CrCbGaD
Prochlorperazine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000715	CcSEcCtD
Prochlorperazine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000714	CcSEcCtD
Prochlorperazine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00071	CcSEcCtD
Prochlorperazine—Acepromazine—ALB—chronic obstructive pulmonary disease	0.000149	0.0128	CrCbGaD
Prochlorperazine—Methotrimeprazine—HTR2A—chronic obstructive pulmonary disease	0.000149	0.0128	CrCbGaD
Prochlorperazine—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.0127	CrCbGaD
Prochlorperazine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	0.000147	0.0126	CrCbGaD
Prochlorperazine—Promethazine—HTR2A—chronic obstructive pulmonary disease	0.000147	0.0126	CrCbGaD
Prochlorperazine—Thioproperazine—ALB—chronic obstructive pulmonary disease	0.000146	0.0125	CrCbGaD
Prochlorperazine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	0.000145	0.0124	CrCbGaD
Prochlorperazine—Loxapine—HTR2A—chronic obstructive pulmonary disease	0.000144	0.0123	CrCbGaD
Prochlorperazine—Pipotiazine—ALB—chronic obstructive pulmonary disease	0.000144	0.0123	CrCbGaD
Prochlorperazine—Thiothixene—ALB—chronic obstructive pulmonary disease	0.000144	0.0123	CrCbGaD
Prochlorperazine—Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.000144	0.0123	CrCbGaD
Prochlorperazine—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.0123	CrCbGaD
Prochlorperazine—Quetiapine—HTR2A—chronic obstructive pulmonary disease	0.000141	0.012	CrCbGaD
Prochlorperazine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.0115	CrCbGaD
Prochlorperazine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.0115	CrCbGaD
Prochlorperazine—Desipramine—HTR2A—chronic obstructive pulmonary disease	0.000134	0.0114	CrCbGaD
Prochlorperazine—Promazine—HTR2A—chronic obstructive pulmonary disease	0.000129	0.0111	CrCbGaD
Prochlorperazine—Clozapine—HTR2A—chronic obstructive pulmonary disease	0.000121	0.0103	CrCbGaD
Prochlorperazine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	0.000114	0.00973	CrCbGaD
Prochlorperazine—Clomipramine—ALB—chronic obstructive pulmonary disease	0.000114	0.00971	CrCbGaD
Prochlorperazine—Imipramine—HTR2A—chronic obstructive pulmonary disease	0.000113	0.00968	CrCbGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.39e-05	0.00142	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.35e-05	0.00141	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.33e-05	0.00141	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.2e-05	0.00139	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.2e-05	0.00139	CbGpPWpGaD
Prochlorperazine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.1e-05	0.00137	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.07e-05	0.00137	CbGpPWpGaD
Prochlorperazine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.99e-05	0.00136	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.9e-05	0.00135	CbGpPWpGaD
Prochlorperazine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.86e-05	0.00134	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.76e-05	0.00132	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.74e-05	0.00132	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	8.68e-05	0.00131	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.68e-05	0.00131	CbGpPWpGaD
Prochlorperazine—DRD2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	8.66e-05	0.00131	CbGpPWpGaD
Prochlorperazine—DRD3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.46e-05	0.00128	CbGpPWpGaD
Prochlorperazine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.4e-05	0.00127	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.39e-05	0.00127	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.33e-05	0.00126	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.33e-05	0.00126	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.29e-05	0.00125	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.29e-05	0.00125	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.28e-05	0.00125	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.24e-05	0.00124	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.22e-05	0.00124	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.18e-05	0.00124	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.12e-05	0.00123	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.09e-05	0.00122	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.05e-05	0.00122	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.97e-05	0.0012	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.96e-05	0.0012	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.84e-05	0.00118	CbGpPWpGaD
Prochlorperazine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	7.79e-05	0.00666	CrCbGaD
Prochlorperazine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.56e-05	0.00114	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.52e-05	0.00114	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.46e-05	0.00113	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.31e-05	0.0011	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.27e-05	0.0011	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.25e-05	0.0011	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.19e-05	0.00109	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.18e-05	0.00108	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.12e-05	0.00108	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.06e-05	0.00107	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.05e-05	0.00107	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.01e-05	0.00106	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	6.76e-05	0.00102	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.73e-05	0.00102	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.64e-05	0.001	CbGpPWpGaD
Prochlorperazine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	6.58e-05	0.000994	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.52e-05	0.000985	CbGpPWpGaD
Prochlorperazine—DRD2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	6.47e-05	0.000978	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.42e-05	0.00097	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.41e-05	0.000969	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.36e-05	0.000961	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.34e-05	0.000959	CbGpPWpGaD
Prochlorperazine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.31e-05	0.000953	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.3e-05	0.000952	CbGpPWpGaD
Prochlorperazine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	6.25e-05	0.000945	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.23e-05	0.000941	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.22e-05	0.00094	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.2e-05	0.000937	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.13e-05	0.000926	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.04e-05	0.000913	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.99e-05	0.000906	CbGpPWpGaD
Prochlorperazine—DRD3—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	5.88e-05	0.000889	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.83e-05	0.000881	CbGpPWpGaD
Prochlorperazine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.8e-05	0.000876	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.76e-05	0.00087	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.72e-05	0.000864	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.51e-05	0.000833	CbGpPWpGaD
Prochlorperazine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.49e-05	0.00083	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.44e-05	0.000822	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.42e-05	0.000819	CbGpPWpGaD
Prochlorperazine—DRD3—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	5.38e-05	0.000814	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.36e-05	0.000809	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.2e-05	0.000785	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.15e-05	0.000778	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.13e-05	0.000774	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.12e-05	0.000774	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.05e-05	0.000764	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.99e-05	0.000754	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.97e-05	0.000751	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.88e-05	0.000737	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.87e-05	0.000735	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.86e-05	0.000735	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.78e-05	0.000722	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.72e-05	0.000713	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.7e-05	0.00071	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.69e-05	0.000708	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.64e-05	0.000702	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.59e-05	0.000693	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.5e-05	0.00068	CbGpPWpGaD
Prochlorperazine—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	4.5e-05	0.00068	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.48e-05	0.000677	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.44e-05	0.000671	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.44e-05	0.000671	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.43e-05	0.000669	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4.42e-05	0.000668	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.42e-05	0.000668	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	4.36e-05	0.000658	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.25e-05	0.000643	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.22e-05	0.000637	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.16e-05	0.000629	CbGpPWpGaD
Prochlorperazine—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	4.12e-05	0.000623	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.1e-05	0.000619	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.09e-05	0.000618	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.06e-05	0.000614	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.05e-05	0.000612	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.02e-05	0.000608	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.02e-05	0.000608	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.96e-05	0.000598	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.92e-05	0.000593	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.92e-05	0.000592	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.85e-05	0.000582	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.85e-05	0.000581	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.83e-05	0.000579	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.79e-05	0.000572	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.79e-05	0.000572	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.75e-05	0.000566	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.72e-05	0.000562	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.69e-05	0.000557	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.65e-05	0.000552	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.6e-05	0.000543	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.59e-05	0.000542	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.52e-05	0.000532	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.48e-05	0.000526	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.46e-05	0.000523	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.26e-05	0.000492	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.25e-05	0.000491	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.22e-05	0.000486	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.2e-05	0.000483	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.15e-05	0.000475	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.02e-05	0.000456	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.93e-05	0.000442	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.89e-05	0.000437	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.87e-05	0.000434	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.87e-05	0.000433	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.85e-05	0.00043	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.82e-05	0.000425	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.79e-05	0.000421	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.77e-05	0.000419	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.67e-05	0.000403	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.65e-05	0.0004	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.63e-05	0.000397	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.62e-05	0.000395	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.61e-05	0.000395	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.58e-05	0.000389	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.51e-05	0.00038	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.51e-05	0.000379	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.49e-05	0.000376	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.46e-05	0.000372	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.42e-05	0.000365	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.38e-05	0.00036	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.38e-05	0.000359	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.35e-05	0.000355	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.34e-05	0.000353	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.28e-05	0.000344	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.26e-05	0.000342	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.21e-05	0.000335	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.2e-05	0.000332	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.18e-05	0.000329	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.17e-05	0.000329	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.16e-05	0.000326	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.15e-05	0.000324	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.14e-05	0.000323	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.12e-05	0.000321	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.03e-05	0.000306	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.01e-05	0.000304	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2e-05	0.000302	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.98e-05	0.000299	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.97e-05	0.000298	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.96e-05	0.000296	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.94e-05	0.000294	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.93e-05	0.000292	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.92e-05	0.000291	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.92e-05	0.00029	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.89e-05	0.000285	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.86e-05	0.000281	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.83e-05	0.000277	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.79e-05	0.00027	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.76e-05	0.000265	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.75e-05	0.000264	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.73e-05	0.000261	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.67e-05	0.000252	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.65e-05	0.000249	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.63e-05	0.000246	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.59e-05	0.00024	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.56e-05	0.000235	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.55e-05	0.000235	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.54e-05	0.000232	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.52e-05	0.000229	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.52e-05	0.000229	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.48e-05	0.000223	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.47e-05	0.000222	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.44e-05	0.000218	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000217	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.42e-05	0.000215	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.4e-05	0.000212	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.4e-05	0.000212	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.4e-05	0.000212	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.38e-05	0.000208	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.36e-05	0.000205	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.35e-05	0.000203	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.34e-05	0.000202	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.32e-05	0.000199	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.29e-05	0.000196	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000195	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.28e-05	0.000193	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.26e-05	0.000191	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.22e-05	0.000184	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.19e-05	0.00018	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.17e-05	0.000176	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.16e-05	0.000175	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.15e-05	0.000173	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.13e-05	0.000171	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.13e-05	0.000171	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.11e-05	0.000168	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.09e-05	0.000165	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.09e-05	0.000165	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000163	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.07e-05	0.000162	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.06e-05	0.000161	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.06e-05	0.000159	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.04e-05	0.000157	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1e-05	0.000152	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.91e-06	0.00015	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.84e-06	0.000149	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	9.77e-06	0.000148	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.65e-06	0.000146	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.53e-06	0.000144	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.47e-06	0.000143	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.4e-06	0.000142	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	9.34e-06	0.000141	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.32e-06	0.000141	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.86e-06	0.000134	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.72e-06	0.000132	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.7e-06	0.000131	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.68e-06	0.000131	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.56e-06	0.000129	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.53e-06	0.000129	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.39e-06	0.000127	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.26e-06	0.000125	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.56e-06	0.000114	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.29e-06	0.00011	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.16e-06	0.000108	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.04e-06	0.000106	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.67e-06	0.000101	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.55e-06	9.9e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.45e-06	9.74e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.39e-06	9.65e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.11e-06	9.23e-05	CbGpPWpGaD
